Telescope Innovations Corp. Reports Q2 Financial Results

Telescope Innovations Corp. Reports Q2 Financial Results Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) has released its Q2 financial results for the period ended February 28, 2025.

Revenue Growth Revenues reached $1,004,121 in Q2 2025, up from $686,205 for the same period in FY 2024.

Operating Expenses The company incurred operating expenses of $1,717,470 in Q2 2025, an increase from $1,277,418 for the same period in FY 2024.

Adjusted EBITA Loss Telescope reported an adjusted EBITA loss of $441,837 in Q2 2025, compared to a loss of $325,488 in the same period in FY 2024.

Product Expansion The company expanded its product offerings into China, and its global distribution partner, Mettler Toledo, launched the distribution of Telescope's DirectInject-LC product in the country.

User Forum Telescope hosted its first user forum with Mettler Toledo, further strengthening its partnerships and collaboration.

Product Demonstrations The company executed product demonstrations at large accounts in expanded geographic markets, advancing the commercial adoption of its products.

White Paper Publication Telescope published a new White Paper on its accessory product to DirectInject-LC, highlighting the co-development of a sampling filter accessory named the EasyFrit.

SDL Project Update The company made significant progress on its Self-Driving Lab (SDL) project, a collaboration with Pfizer, using AI, advanced process analytical technology, and robotic automation.

Brine-to-Battery Program Success Telescope successfully completed the Brine-to-Battery program, producing battery-grade lithium carbonate from North American lithium-containing brines, reducing refining costs.